Fate Therapeutics, Inc. (FATE) vs Fulcrum Therapeutics, Inc. (FULC)
A side-by-side comparison of Fate Therapeutics, Inc. and Fulcrum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FATE
Fate Therapeutics, Inc.
$2.34HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
FULC
Fulcrum Therapeutics, Inc.
$3.70HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — FATE vs FULC
growth of $100 · dividends reinvested · last 7yFATE -89.2% (-27.2%/yr)FULC -72.5% (-16.8%/yr)FULC compounded faster over this window
FATE FULC
FATE vs FULC: by the numbers
- •FULC is the larger company ($282M vs $272M market cap).
- •Both run net losses; FULC's is the smaller (0.00% vs -1941.09% net margin).
Metrics side by side
Valuation
| Metric | FATE | FULC |
|---|---|---|
| P/S ratio | 41.93 | N/A |
| P/B ratio | 1.77 | 0.91 |
Profitability
| Metric | FATE | FULC |
|---|---|---|
| Gross margin | -94.12% | 0.00% |
| Operating margin | -2222.45% | 0.00% |
| Net margin | -1941.09% | 0.00% |
| ROE | -82.12% | -27.36% |
| ROIC | -58.72% | -27.62% |
Growth (annualized)
| Metric | FATE | FULC |
|---|---|---|
| Revenue CAGR (5Y) | -32.98% | N/A |
| Total return CAGR (5Y) | -46.86% | -31.70% |
Frequently asked
- How have FATE and FULC total returns compared?
- Over the past 5 years, FATE delivered -46.86% and FULC delivered -31.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.